新型监测技术或可有效帮助肺癌个性化治疗

  近日，在美国放射治疗学和肿瘤学协会年会上，来自洛约拉大学 ( Loyola University )的研究人员通过研究开发了一种新型技术，其可有效帮助进行早期肺癌放疗期间患者机体肿瘤的监测。
  会议上，John Roeske博士揭示了他们开发及评估该新型技术的一些进展情况；这种新型技术利用双能量成像结合荧光透视法技术来在患者放疗期间对其机体的肿瘤进行观察，该技术并不需要能够产生高能和低能成像的X射线；现有的硬件可以用于消除视觉效果的弊端从而使得研究人员更加清晰地观察到肿瘤。
  Roeske教授表示，双能量成像技术已经被放射线学家使用了很多年用于检测肺部肿瘤，当将其同荧光透视法结合后，杂交的双能量技术将可以增强对肿瘤的可视性从而有效改善对患者的治疗。目前研究人员已经申请了该技术的专利，他们报道说，如果该技术可以可以商用的话，将为医院带来不菲的价值。
  最后研究人员说道，尽管这种新型技术可以利用软件的途径来产生双能量成像，但是医院并不需要替换当前标准的X射线机，新型的杂交技术（结合技术）可以有效移除当前的技术障碍来为临床医生和病人带来极大好处。（转化医学网360zhyx.com）
  本文系转化医学网原创翻译整理，欢迎转载！转载请注明来源并附原文链接。谢谢！
转化医学网推荐的新闻阅读：

John Roeske, PhD, and colleagues presented how they developed and evaluated the technology at the recent annual meeting of the American Society for Therapeutic Radiology and Oncology.
Their approach uses dual-energy imaging combined with fluoroscopy to view tumors during radiation therapy. This technology does not require an X-ray that produces both high-and low-energy images. Existing hardware can be used to eliminate visuals of the ribs and other bones making it easier to see the tumor.
"Dual-energy imaging has been used for decades by radiologists to detect lung tumors," said Roeske, professor and director of Radiation Physics, Department of Radiation Oncology. "When combined with fluoroscopy, the hybrid dual-energy technology can enhance the visibility of tumors to improve treatment for patients."
Roeske and his colleagues have a patent on the technology. They report that if it becomes commercially available, their approach would provide a cost-benefit to hospitals.
"This technology does not require that hospitals replace their standard X-ray machines since the dual-energy images are created using a software approach," Roeske said. "The hybrid technique removes present obstacles making this a great benefit to clinicians and patients."